Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 16.7% increase over the number of companies inspected in the previous quarter, when six companies received six inspections.
Most of the companies inspected at the time were involved in the Biologics sector. Both the Devices and Food and Cosmetics sectors sectors tied for second most common type.
There were six companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Greenwich Fertility & Ivf Center, P.C. | Biologics | 12/06/2023 | No Action Indicated (NAI) |
Memry Corporation | Devices | 12/01/2023 | No Action Indicated (NAI) |
Mutti USA, Inc. | Food and Cosmetics | 10/16/2023 | No Action Indicated (NAI) |
New England Fertility Institute | Biologics | 11/07/2023 | No Action Indicated (NAI) |
Remote Technologies, Inc. | Devices | 11/08/2023 | Voluntary Action Indicated (VAI) |
ReproTech, LLC | Biologics | 10/20/2023 | No Action Indicated (NAI) |
TCP HRB Acquisiton, LLC | Food and Cosmetics | 12/28/2023 | No Action Indicated (NAI) |